Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Common HIV drug-drug interactions.

L W O'Brien1

  • 1Department of Pharmacy, New York Presbyterian Hospital, New York, NY, USA.

The AIDS Reader
|May 6, 2003
PubMed
Summary
This summary is machine-generated.

Patients with human immunodeficiency virus (HIV) often take multiple daily medications. These drug regimens, while improving survival, increase the risk of dangerous drug interactions, especially with protease inhibitors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional partial dentures.

Bulletin of the U.S. Army Medical Department. United States. Army. Medical Department·2010
Same author

Tricho-dento-osseous syndrome.

Journal of endodontics·1976
Same author

Halitosis; variations in mouth and total breath odor intensity resulting from prophylaxis and antisepsis.

Journal of dental research·1947
Same journal

Effect of antiretroviral resistance on response in treatment-experienced patients.

The AIDS reader·2009
Same journal

Maximizing treatment outcome: key considerations for antiretroviral-experienced patients.

The AIDS reader·2009
Same journal

Utilizing a new class of antiretrovirals: role of fusion inhibitors in HIV disease management.

The AIDS reader·2009
Same journal

Economic crisis threatens AIDS fight.

The AIDS reader·2009
Same journal

Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this?

The AIDS reader·2009
Same journal

Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.

The AIDS reader·2009
See all related articles

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Patients with human immunodeficiency virus (HIV) are prescribed complex daily medication regimens.
  • These regimens typically include antiretroviral therapy, prophylactic drugs, and other necessary medications.
  • While effective in improving survival and reducing opportunistic infections, these treatments carry risks.

Purpose of the Study:

  • To highlight the significant issue of drug interactions in patients with HIV.
  • To underscore the challenges clinicians face in managing polypharmacy in HIV treatment.
  • To emphasize the role of specific drug classes, like protease inhibitors, in exacerbating drug interaction risks.

Main Methods:

  • Literature review of current HIV treatment protocols.

Related Experiment Videos

  • Analysis of reported adverse drug events and interactions in HIV patients.
  • Examination of the pharmacokinetic and pharmacodynamic profiles of commonly used HIV medications.

    • Main Results:

    • HIV treatment regimens involve multiple drugs, increasing the potential for adverse interactions.
    • Protease inhibitors are frequently associated with a higher incidence of drug-drug interactions.
    • Managing these interactions is crucial for patient safety and treatment efficacy.

    Conclusions:

    • The complexity of HIV pharmacotherapy necessitates careful monitoring for drug interactions.
    • Clinicians must be vigilant regarding potential interactions, particularly those involving protease inhibitors.
    • Further research and clinical guidelines are needed to optimize drug management in HIV patients.